Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-11-07
1999-01-12
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, A61K 3156
Patent
active
058590005
ABSTRACT:
The present invention is directed to a method for reducing mast cell mediated allergic reactions, including mast cell mediated allergy and asthma. Mast cell mediated allergic reactions, including type I hypersensitivity reasponse to allergens and asthma, are reduced by administering a dehydroepiandrosterone (DHEA) derivative to a patient in a manner which quickly raises blood levels of the active agent.
REFERENCES:
patent: 5489581 (1996-02-01), Daynes et al.
patent: 5532230 (1996-07-01), Daynes et al.
patent: 5540919 (1996-07-01), Daynes et al.
Araneo Barbara A.
Dowell Tad
Norton Steven D.
Henley III Raymond J.
Pharmadigm, Inc.
University of Utah Research Foundation
LandOfFree
Method for reducing mast cell mediated allergic reactions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing mast cell mediated allergic reactions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing mast cell mediated allergic reactions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516180